190 related articles for article (PubMed ID: 35764172)
1. A peptoid-based inhibitor of protein arginine methyltransferase 1 (PRMT1) induces apoptosis and autophagy in cancer cells.
Brekker MA; Sartawi T; Sawatzky TM; Causey CP; Rehman FK; Knuckley B
J Biol Chem; 2022 Aug; 298(8):102205. PubMed ID: 35764172
[TBL] [Abstract][Full Text] [Related]
2. Histone H4-based peptoids are inhibitors of protein arginine methyltransferase 1 (PRMT1).
Mann SA; DeMart MK; May B; Causey CP; Knuckley B
Biochem J; 2020 Aug; 477(16):2971-2980. PubMed ID: 32716034
[TBL] [Abstract][Full Text] [Related]
3. Transient Kinetics Define a Complete Kinetic Model for Protein Arginine Methyltransferase 1.
Hu H; Luo C; Zheng YG
J Biol Chem; 2016 Dec; 291(52):26722-26738. PubMed ID: 27834681
[TBL] [Abstract][Full Text] [Related]
4. Promising role of protein arginine methyltransferases in overcoming anti-cancer drug resistance.
Zhu Y; Xia T; Chen DQ; Xiong X; Shi L; Zuo Y; Xiao H; Liu L
Drug Resist Updat; 2024 Jan; 72():101016. PubMed ID: 37980859
[TBL] [Abstract][Full Text] [Related]
5. The arginine methyltransferase PRMT5 and PRMT1 distinctly regulate the degradation of anti-apoptotic protein CFLAR
Li M; An W; Xu L; Lin Y; Su L; Liu X
J Exp Clin Cancer Res; 2019 Feb; 38(1):64. PubMed ID: 30736843
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous ablation of prmt-1 and prmt-5 abolishes asymmetric and symmetric arginine dimethylations in Caenorhabditis elegans.
Hirota K; Shigekawa C; Araoi S; Sha L; Inagawa T; Kanou A; Kako K; Daitoku H; Fukamizu A
J Biochem; 2017 Jun; 161(6):521-527. PubMed ID: 28158808
[TBL] [Abstract][Full Text] [Related]
7. Understanding protein arginine methyltransferase 1 (PRMT1) product specificity from molecular dynamics.
Gathiaka S; Boykin B; Cáceres T; Hevel JM; Acevedo O
Bioorg Med Chem; 2016 Oct; 24(20):4949-4960. PubMed ID: 27545444
[TBL] [Abstract][Full Text] [Related]
8. Type I Arginine Methyltransferases PRMT1 and PRMT-3 Act Distributively.
Kölbel K; Ihling C; Bellmann-Sickert K; Neundorf I; Beck-Sickinger AG; Sinz A; Kühn U; Wahle E
J Biol Chem; 2009 Mar; 284(13):8274-82. PubMed ID: 19158082
[TBL] [Abstract][Full Text] [Related]
9. PRMT blockade induces defective DNA replication stress response and synergizes with PARP inhibition.
Li Y; Dobrolecki LE; Sallas C; Zhang X; Kerr TD; Bisht D; Wang Y; Awasthi S; Kaundal B; Wu S; Peng W; Mendillo ML; Lu Y; Jeter CR; Peng G; Liu J; Westin SN; Sood AK; Lewis MT; Das J; Yi SS; Bedford MT; McGrail DJ; Sahni N
Cell Rep Med; 2023 Dec; 4(12):101326. PubMed ID: 38118413
[TBL] [Abstract][Full Text] [Related]
10. A remodeled protein arginine methyltransferase 1 (PRMT1) generates symmetric dimethylarginine.
Gui S; Gathiaka S; Li J; Qu J; Acevedo O; Hevel JM
J Biol Chem; 2014 Mar; 289(13):9320-7. PubMed ID: 24478314
[TBL] [Abstract][Full Text] [Related]
11. Activity-based protein profiling of protein arginine methyltransferase 1.
Obianyo O; Causey CP; Jones JE; Thompson PR
ACS Chem Biol; 2011 Oct; 6(10):1127-35. PubMed ID: 21838253
[TBL] [Abstract][Full Text] [Related]
12. Mouse Models of Overexpression Reveal Distinct Oncogenic Roles for Different Type I Protein Arginine Methyltransferases.
Bao J; Di Lorenzo A; Lin K; Lu Y; Zhong Y; Sebastian MM; Muller WJ; Yang Y; Bedford MT
Cancer Res; 2019 Jan; 79(1):21-32. PubMed ID: 30352814
[TBL] [Abstract][Full Text] [Related]
13. The C. elegans PRMT-3 possesses a type III protein arginine methyltransferase activity.
Takahashi Y; Daitoku H; Yokoyama A; Nakayama K; Kim JD; Fukamizu A
J Recept Signal Transduct Res; 2011 Apr; 31(2):168-72. PubMed ID: 21385054
[TBL] [Abstract][Full Text] [Related]
14. The macromolecular complexes of histones affect protein arginine methyltransferase activities.
Fulton MD; Cao M; Ho MC; Zhao X; Zheng YG
J Biol Chem; 2021 Oct; 297(4):101123. PubMed ID: 34492270
[TBL] [Abstract][Full Text] [Related]
15. Redox Control of Protein Arginine Methyltransferase 1 (PRMT1) Activity.
Morales Y; Nitzel DV; Price OM; Gui S; Li J; Qu J; Hevel JM
J Biol Chem; 2015 Jun; 290(24):14915-26. PubMed ID: 25911106
[TBL] [Abstract][Full Text] [Related]
16. Protein arginine N-methyltransferase substrate preferences for different nη-substituted arginyl peptides.
Thomas D; Koopmans T; Lakowski TM; Kreinin H; Vhuiyan MI; Sedlock SA; Bui JM; Martin NI; Frankel A
Chembiochem; 2014 Jul; 15(11):1607-13. PubMed ID: 25044481
[TBL] [Abstract][Full Text] [Related]
17. Protein arginine methyltransferase 1 is a therapeutic vulnerability in multiple myeloma.
Nguyen HP; Le AQ; Liu E; Cesarano A; DiMeo F; Perna F; Kapur R; Walker BA; Tran NT
Front Immunol; 2023; 14():1239614. PubMed ID: 37600810
[TBL] [Abstract][Full Text] [Related]
18. PRMT1 expression is elevated in head and neck cancer and inhibition of protein arginine methylation by adenosine dialdehyde or PRMT1 knockdown downregulates proliferation and migration of oral cancer cells.
Chuang CY; Chang CP; Lee YJ; Lin WL; Chang WW; Wu JS; Cheng YW; Lee H; Li C
Oncol Rep; 2017 Aug; 38(2):1115-1123. PubMed ID: 28656289
[TBL] [Abstract][Full Text] [Related]
19. Functional Study of
Lorenzon L; Quilles JC; Campagnaro GD; Azevedo Orsine L; Almeida L; Veras F; Miserani Magalhães RD; Alcoforado Diniz J; Rodrigues Ferreira T; Kaysel Cruz A
ACS Infect Dis; 2022 Mar; 8(3):516-532. PubMed ID: 35226477
[TBL] [Abstract][Full Text] [Related]
20. Kinetic mechanism of protein arginine methyltransferase 1.
Obianyo O; Osborne TC; Thompson PR
Biochemistry; 2008 Sep; 47(39):10420-7. PubMed ID: 18771293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
